FDA releases Biosimilar Action Plan
What you need to know about the latest FDA approval.
Brand-name drug companies are finding creative ways to extend patent protection, causing patient access problems.
New drugs for acute migraines are almost ready for prime time. Here's what you need to know.
Not too long ago, it seemed like anything could end up in a pharmacy—with disastrous (or sometimes just humorous) results.
Affected Products Sold at Walgreens, CVS, Walmart, and Kroger Stores.
How one health system is coping is coping with the shortages.
Signs point to a cooling on the FDA's fiery approval pace of 2017, but 2018 has already seen five novel drug approvals.
Zinbryta was taken off the market, leaving many patients with poor options.
Learning more about popular dietary supplements could further cement pharmacists’ position in the healthcare industry, helping them gain recognition as healthcare providers.